Qual é o preço para Probi AB (publ) (PROB)

O preço para Probi AB (publ) (PROB) é $38.87

Qual é a capitalização de mercado para Probi AB (publ) (PROB)

A capitalização de mercado para Probi AB (publ) (PROB) é $442.88M

Probi AB (publ) (PROB) Índice P/L

Probi AB (publ) specializes in the research, development, manufacturing, marketing, and distribution of probiotics for the health, pharmaceutical, and food sectors. The company's scientific endeavors primarily focus on areas such as gastrointestinal, digestive, immune, and bone health, as well as iron absorption, and the specific health requirements of children, women, and seniors. Their product range includes dietary supplements and various food and beverage applications, offered in diverse formats like capsules, tablets (including chewable), spheres, powders, and an array of drinks such as fruit drinks, shots, carbonated beverages, and recovery drinks. Probi's products are sold in approximately 40 countries globally. The company also fosters collaborations, including a partnership with Örebro University for exploring needle-free vaccines and with La Trobe University for a clinical trial assessing the effects of Probi Osteo in Australian women. Established in 1991 and headquartered in Lund, Sweden, Probi AB (publ) operates as a subsidiary of Symrise AG.

Ano	Índice P/E	Alterar
Não há dados suficientes para as datas fornecidas.

Ano

Índice P/E

Alterar

Não há dados suficientes para as datas fornecidas.

Empresa	Rácio P/E	Diferença do rácio P/E	País
MERCK Kommanditgesellschaft auf Aktien MER.SW	-	-	DE
Merck KGaA MRK.DE	-	-	DE
Takeda Pharmaceutical Company Limited 4502.T	-	-	JP
Sun Pharmaceutical Industries Limited SUNPHARMA.NS	38.29	-	IN
Galderma Group AG GALD.SW	-	-	CH

Empresa

Rácio P/E

Diferença do rácio P/E

País